FDA Approves Alternative Standard Breast Density Reporting
The Alternative Standard will allow the physician to provide an overall assessment of breast density with singular phrasing in reports of unilateral mammograms.
Read moreIn our commitment to advocate for the highest-quality imaging standards, an important update has been made to phantom criteria and testing for ACR® Nuclear Medicine- and PET-accredited sites. These accreditation changes take effect Jan. 1, 2024.
Effective Jan. 1, 2024, the mean background criteria for PET phantoms will be changing to 0.90-1.10 for SUV measurements.
Please refer to the Phantom Criteria (Revised 6-21-23) article for details.
Effective Jan. 1, 2024, the definition of a small rectangular field camera for NM phantoms will be changing to smallest dimension < 32 cm (currently it states: longest dimension < 32 cm).
Please refer to the Phantom Testing: Nuclear Medicine (Revised 6-21-23) article for details.
Review the requirements carefully before submitting testing items for accreditation review. Requirements are subject to change at any time. Check ACR requirements frequently for updates.
If you have questions, please submit a support ticket. Select "Accreditation" for Support Team and "Ultrasound/NM/PET Technical" for category.
FDA Approves Alternative Standard Breast Density Reporting
The Alternative Standard will allow the physician to provide an overall assessment of breast density with singular phrasing in reports of unilateral mammograms.
Read moreDirect Supervision for Contrast Studies
We recommend that sites follow the ACR CT and MR Accreditation requirements for onsite supervision of contrast administration and management.
Read moreMQSA Small Entity Compliance Guide
The U.S. FDA issued a Small Entity Compliance Guide to assist small entities, including mammography facilities, in complying with the 2023 MQSA Rule.
Read more